Algo version: 0.98b
FOLD is listed at the NASDAQ Exchange
FOLD [FOLD]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is FOLD stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Amicus Therapeutics Inc 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $7.47, you would have made a profit of $4.20 per share or 56.22%

Yes, the average daily trading liquidity for Amicus Therapeutics Inc is $27.39 million. You should therefore be able to get in and out of your positions relatively fast.

Amicus Therapeutics Inc has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Amicus Therapeutics Inc to be high [1 out of 1]